Short NJ,Rytting ME,Cortes JE .2018 .Acute myeloid leukaemia. Lancet, 6736(18) : 31041-9.
Bhansali RS,Pratz KW,Lai C .2023 .Recent advances in targeted therapies in acute myeloid leukaemia. J Hematol Oncol, 10(1) : 29.
Kooistra SM,Helin K. .2012 .Molecular mechanisms and potential functions of histone demethylases. Nat Rev Mol Cell Biol, 10(5) : 297-311.
Guo JC,Liu Z,Yang YJ,Guo M,Zhang JQ,Zheng JF .2021 .Kdm5b promotes self-renewal of hepatocellular carcinoma cells through the microrna-448-mediated Ythdf3/Itga6 axis. J Cell Mol Med, 10(13) : 5949-62.
Liu B,Kumar R,Chao HP,Mehmood R,Ji Y,Tracz A .2020 .Evidence for context-dependent functions of Kdm5b in prostate development and prostate cancer. Oncotarget, 10(46) : 4243-52.
.2021 .Systemic pro ling of Kdm5 subfamily signature in non-small-cell lung cancer. Int J Gen Med, 10 : 7259-75.
Huang D,Qiu Y,Li G,Liu C,She L,Zhang D .2018 .Kdm5b overexpression predicts a poor prognosis in patients with squamous cell carcinoma of the head and neck. J Cancer, 10(1) : 198-204.
Shokri G,Doudi S,Fathi-Roudsari M,Kouhkan F,Sanati MH .2018 .Targeting histone demethylases Kdm5a and Kdm5b in aml cancer cells: A comparative view. Leuk Res, 02 : 105-11.
Huang J,Jin S,Guo R,Wu W,Yang C,Qin Y .2024 .Histone lysine demethylase Kdm5b facilitates proliferation and suppresses apoptosis in human acute myeloid leukaemia cells through the mir-140-3p/Bcl2 axis. RNA, 10(4) : 435-47.
Ren Z,Kim A,Huang YT,Pi WC,Gong W,Yu X . .A Prc2- Kdm5b axis sustains tumourigenicity of acute myeloid leukaemia. Proc Nat Acad Sci, 10(9) : .
Chan LH,Yan Q.,Awakening Q. .2022 .Kdm5b to defeat leukaemia. Proc Nat Acad Sci USA, 10(13) : .
Montano MM,Yeh IJ,Chen Y,Hernandez C,Kiselar JG,de la Fuente M .2019 .Inhibition of the histone demethylase, Kdm5b, directly induces re-expression of tumour suppressor protein hexim1 in cancer cells. Breast Cancer Res, 10(1) : 138.
Daver N,Manero GG,Basu S,Boddu PC,Alfayez M,Cortes JE .2019 .E cacy, safety, and biomarkers of response to azacitidine and nivolumab in relapsed/refractory acute myeloid leukaemia: A nonrandomized, open-label, phase Ii study. Cancer Discov, 18(3) : 2159-8290.
Bindea G,Mlecnik B,Tosolini M,Kirilovsky A,Waldner M,Obenauf AC .2013 .Spatiotemporal dynamics of intratumoural immune cells reveal the immune landscape in human cancer. Immunity, 10(4) : 782-95.
Thorsson V,Gibbs DL,Brown SD,Wolf D,Bortone DS,Ou Yang TH .2018 .The immune landscape of cancer. Immunity, 03(4) : 812-30.
Danilova L,Ho WJ,Zhu Q,Vithayathil T,De Acosta AJ,Azad NS .2019 .Programmed Cell death ligand-1 (Pd-L1) and Cd8 expression pro ling identify an immunologic subtype of pancreatic ductal adenocarcinomas with favorable survival. Cancer Immunol Res, 18(6) : 2326-6066.
Hanahan D,Coussens LM .2012 .Accessories to the crime: Functions of cells recruited to the tumour micro-environment. Cancer cell, 02(3) : 309-22.
Ganesan S,Mathews V,Vyas N. .2022 .Micro-environment and drug resistance in acute myeloid leukemia: Do we know enough?. Int J Cancer, 10(9) : 1401-11.
Vago L,Gojo I. .2020 .Immune escape and immunotherapy of acute myeloid leukaemia. J Clin Invest, 10(4) : 1552-64.
Li X,Li J,Liu Y,Sun L,Tai Q,Gao S .2023 .Inhibition of Kdm5b participates in immune microenvironment remodeling in pancreatic cancer by inducing sting expression. Cytokine, 156451 : 156451.
Sauerer T,Velazquez GF,Schmid C .2023 .Relapse of acute myeloid leukaemia after allogeneic stem cell transplantation: Immune escape mechanisms and current implications for therapy. Mol Cancer, 10(1) : 180.
Tal SG,Rothenberg ME,Munitz A .2022 .Eosinophil-lymphocyte interactions in the tumour microenvironment and cancer immunotherapy. Nat Immunol, 10(9) : 1309-16.
Fitz-James MH,Cavalli G .2022 .Molecular mechanisms of transgenerational epigenetic inheritance. Nat Rev Genet, 10(6) : 325-41.
Zhang SM,Cai WL,Liu X,Thakral D,Luo J,Chan LH .2021 .Kdm5b promotes immune evasion by recruiting setdb1 to silence retroelements. Nature, 10(7882) : 682-7.
Momparler RL,Cote S,Momparler LF .2021 .5(2):7. Epigenomes, 10 : .